← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #507 OF 1,000 MOST-CITED

Medication status of animal(s)

FDA cited this observation 37 times across 37 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Veterinary Medicine37
BY FISCAL YEAR
FY20264
FY20255
FY20224
FY20203
FY20197
FY20186
FY20178

How FDA worded it — real examples

You did not inquire about the medication status of the animal(s) that you purchased and delivered for sale at an auction barn.

Joshua Brumfield · Chatham, Virginia · Veterinary Medicine · 2026-02-13

You did not inquire about the medication status of the animal(s) that you purchased and delivered for sale at an auction barn.

Samuel K. Stoltzfus · Allenwood, Pennsylvania · Veterinary Medicine · 2025-12-18

You did not inquire about the medication status of the animal(s) that you purchased and delivered for sale and consignment at an auction barn.

Archer Calf Ranch · Merino, Colorado · Veterinary Medicine · 2025-10-31

You did not inquire about the medication status of the animal(s) that you transported and delivered for sale at an auction barn.

Jordan J Weaver · Roann, Indiana · Veterinary Medicine · 2025-10-31

You did not inquire about the medication status of the animal(s) that you purchased and delivered for consignment at a slaughter plant.

Randleman Farms · Elon, North Carolina · Veterinary Medicine · 2025-08-07

You did not inquire about the medication status of the animal(s) that you transported and purchased and delivered for sale at.

Jay Parker & Sons, LLC · North Manchester, Indiana · Veterinary Medicine · 2025-06-16

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Veterinary industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →